Physician profile
Michael S Bloch
NPI 1316029580
$6,015.87
in general payments reported to CMS, 2019-2025
45 companies · $947 in 2025
The $947 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $138 · 2021: $556 · 2022: $1,381 · 2023: $939 · 2024: $712 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,340 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,339.94 |
| Travel and Lodging | $258.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,311.34 | 2021-2025 | Puraply, Apligraf, Via Matrix |
| Biotissue Holdings INC. | $750.25 | 2022-2025 | |
| Treace Medical Concepts, INC. | $604.08 | 2023-2025 | |
| Smith+Nephew, INC. | $415.66 | 2019-2025 | Collagenase Santyl, Regranex, Renasys Go V2 Home |
| Bioventus LLC | $312.87 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $226.28 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $210.35 | 2019-2022 | |
| Wright Medical Technology, INC. | $196.70 | 2019-2020 | |
| Osiris Therapeutics INC. | $178.91 | 2019 | |
| Paragon 28, INC. | $132.79 | 2020-2022 | |
| Linvatec Corporation | $119.02 | 2019-2025 | 5ms |
| Djo, LLC | $116.98 | 2020-2025 | Procare, Aircast, Donjoy |
| Sandoz INC. | $114.71 | 2019 | |
| Depuy Synthes Sales INC. | $110.12 | 2019-2025 | Na, Hammerlock |
| Ani Pharmaceuticals, INC. | $88.14 | 2025 | Purified Cortrophin Gel, Oxistat |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $78.31 | 2022-2023 | Jublia |
| Stryker Corporation | $73.60 | 2021-2025 | Variax, Easyfuse, N/A |
| Melinta Therapeutics, LLC | $70.86 | 2019 | |
| Arthrosurface Incorporated | $69.08 | 2019 | |
| Urgo Medical North America, LLC | $66.22 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| In2bones USA, LLC | $65.12 | 2021 | |
| Nevro Corp. | $51.22 | 2022-2024 | Senza |
| Orthofix Medical, INC. | $50.30 | 2025 | Physio-Stim |
| Polarityte, INC. | $46.93 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $46.59 | 2024-2025 | |
| Bone Support INC. | $45.71 | 2024 | Ceramentbone Void Filler, Cerament G |
| Paratek Pharmaceuticals, INC. | $44.85 | 2023-2025 | Nuzyra |
| Kci USA, INC. | $41.87 | 2019-2020 | |
| Horizon Therapeutics Plc | $41.09 | 2019-2020 | |
| Abbvie INC. | $38.71 | 2022-2025 | |
| Zyla Life Sciences, INC. | $35.59 | 2019 | |
| Mimedx Group, INC. | $29.41 | 2024 | |
| Aroa Biosurgery Incorporated | $29.24 | 2022 | |
| Crossroads Extremity Systems, LLC | $27.06 | 2019 | |
| Averitas Pharma INC. | $21.95 | 2023 | Qutenza |
| Kerecis Limited | $21.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kowa Pharmaceuticals America, INC. | $20.49 | 2022 | |
| Terumo Bct, INC. | $16.66 | 2019 | |
| Sanara Medtech INC. | $16.03 | 2025 | Celleraterx |
| Cardiovascular Systems INC. | $15.81 | 2020 | |
| Nabriva Therapeutics, Plc | $13.84 | 2021 | |
| Saxum Surgical, INC. | $13.50 | 2022 | |
| Assertio Therapeutics, INC. | $12.65 | 2019 | |
| Acell, INC. | $12.29 | 2019 | |
| Bsn Medical INC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bloch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.